Contact
searchSearch
HMP Global

Volume 20 - Issue 5 - May 2023

Feature

Review
Geniculate Artery Embolization: A Review of Hemarthrosis and Osteoarthritis
05/17/2023
Jacob L. Beltz, MD; Nicole A. Keefe, MD
This review demonstrates support for the efficacy of geniculate artery embolization and describes the common techniques, with the goal to propagate its use where appropriate to give many patients a chance for improvement in symptoms.
This review demonstrates support for the efficacy of geniculate artery embolization and describes the common techniques, with the goal to propagate its use where appropriate to give many patients a chance for improvement in symptoms.
This review demonstrates support...
05/17/2023
Vascular Disease Management
Case Report with Review
Multidisciplinary Management of Cervical Ectopic Pregnancy: A Report of Two Cases
05/17/2023
Gloria Salazar, MD, FSIR; Priya Mody, MD
Two cases are presented of patients who had minimal intraoperative blood loss secondary to IR placement of intra-arterial occlusion balloons prior to evacuation of cervical ectopic pregnancy.
Two cases are presented of patients who had minimal intraoperative blood loss secondary to IR placement of intra-arterial occlusion balloons prior to evacuation of cervical ectopic pregnancy.
Two cases are presented of...
05/17/2023
Vascular Disease Management
Case Report With Review
An Unusual Cause of Pelvic Congestion Syndrome
05/17/2023
Kumar Muthukumar, MBBS, DMRD, FRCR, DNB, FNVIR; Santhosh Babu Bharathy, MD, MBBS; Shoban Haridass, MBBS, MD, DM, DNB; Vinu Moses, MD, DNB, MBBS; Selvaraj Deepak, MBBS, MS, MCh, MRCS; Shyamkumar Nidugala Keshava, MBBS, DMRD, DNB, FRCR, FRANZCR
In this case, the symptoms of PCS resulted secondary to venous obstruction. A variant form of May-Thurner syndrome was identified on contrast-enhanced CT, where the common trunk of the IIVs was compressed by the right common iliac artery.
In this case, the symptoms of PCS resulted secondary to venous obstruction. A variant form of May-Thurner syndrome was identified on contrast-enhanced CT, where the common trunk of the IIVs was compressed by the right common iliac artery.
In this case, the symptoms of...
05/17/2023
Vascular Disease Management

Insights

Interview
Genicular Artery Embolization in 2023: An Interview With Dr. Osman Ahmed
05/17/2023
Osman Ahmed, MD
VDM spoke with Dr. Ahmed to discuss the latest studies on GAE for OA of the knee and what their results mean for the future of this treatment.
VDM spoke with Dr. Ahmed to discuss the latest studies on GAE for OA of the knee and what their results mean for the future of this treatment.
VDM spoke with Dr. Ahmed to...
05/17/2023
Vascular Disease Management
Interview
Dual Therapy Following Iliocaval and Iliofemoral Deep Vein Thrombosis Thrombectomy: An Interview With Dr. Gregg Khodorov
05/17/2023
Gregg Khodorov, MD, MBA
VDM spoke with Dr. Khodorov to discuss the results of the study and what it means for dual therapy regimens for 12-month patency.
VDM spoke with Dr. Khodorov to discuss the results of the study and what it means for dual therapy regimens for 12-month patency.
VDM spoke with Dr. Khodorov to...
05/17/2023
Vascular Disease Management
Video
25 Years of AAA Treatment Innovation
05/01/2023
Ross Milner, MD, provides perspective on the development of a unique delivery system that provided a device repositioning option.
Ross Milner, MD, provides perspective on the development of a unique delivery system that provided a device repositioning option.
Ross Milner, MD, provides...
05/01/2023
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

VentiV Clinical Images
Thrombectomy
FDA Clears New Mechanical Thrombectomy System
03/31/2025
VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
VentiV Scientific announced the...
03/31/2025
Cath Lab Digest
Restenosis
Real-world Data Shows Cook’s Zilver PTX Leads to Lower Rates of In-stent Occlusion Than Boston Scientific’s Eluvia
03/27/2025
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook...
03/27/2025
Vascular Disease Management
TAVR
Medtronic’s Evolut Trial Outcome Could Shake Up US TAVR Market, Says GlobalData
03/21/2025
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results...
03/21/2025
Vascular Disease Management
Embolotherapy
Instylla Completes Submission of Premarket Approval Application for Embrace™ Hydrogel Embolic System
03/11/2025
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025...
03/11/2025
Vascular Disease Management
Resistant Hypertension
Corcept Therapeutics Initiates MOMENTUM Trial to Determine Prevalence of Hypercortisolism in Patients with Resistant Hypertension
03/10/2025
“Resistant hypertension is a serious public health challenge. Patients whose hypertension remains in poor control despite receiving optimal care, including multiple medications, are at greater risk of cardiovascular morbidity and mortality,”...
“Resistant hypertension is a serious public health challenge. Patients whose hypertension remains in poor control despite receiving optimal care, including multiple medications, are at greater risk of cardiovascular morbidity and mortality,”...
“Resistant hypertension is a...
03/10/2025
Cath Lab Digest
Company expansion
Reflow Medical Expands Global Reach With New European Subsidiary
03/06/2025
Reflow Medical, Inc., a developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany.
Reflow Medical, Inc., a developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany.
Reflow Medical, Inc., a...
03/06/2025
Cath Lab Digest
SCAI
Survey Confirms Radiation and Orthopedic Health Hazards in Cardiac Catheterization Laboratories are ‘Unacceptable’
03/05/2025
A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory (“cath lab” or CCL)...
A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory (“cath lab” or CCL)...
A survey conducted by the...
03/05/2025
Cath Lab Digest
Shockwave Javelin Peripheral IVL Catheter, a novel intravascular lithotripsy (IVL) platform designed to modify calcium and cross extremely narrowed vessels in patients with peripheral artery disease (PAD).
IVL
Shockwave Medical Launches Novel Forward Intravascular Lithotripsy Platform in U.S. to Transform Treatment of Difficult-to-Cross Calcified Lesions
03/04/2025
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease.
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease.
Now available in the U.S., the...
03/04/2025
Cath Lab Digest
Acute Ischemic Stroke
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
03/03/2025
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the...
03/03/2025
Vascular Disease Management
TEVAR
Zenith Alpha Thoracic 2 Now Available in US; First Case Performed
03/03/2025
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2...
03/03/2025
Vascular Disease Management

May 2023 Volume 20 Issue 5

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use